Status:

RECRUITING

Cue Effects in Human Addiction: Pavlovian to Instrumental Transfer

Lead Sponsor:

Charite University, Berlin, Germany

Collaborating Sponsors:

Technische Universität Dresden

Conditions:

Alcohol Use Disorder (AUD)

Alcoholism

Eligibility:

All Genders

16-65 years

Brief Summary

Individuals with substance use disorders (SUD) have to cope with drug-related cues and contexts, which can affect instrumental drug seeking as shown with Pavlovian to instrumental transfer (PIT) parad...

Detailed Description

This project has four research aims: 1. The investigators want to assess the effects of acute as well as repeated stress exposure on PIT and its neuroimaging correlates, and the investigators will te...

Eligibility Criteria

Inclusion

  • males and females between 16-65 years of age
  • AUD subjects only: meet a minimum of 2 criteria for DSM-5 alcohol-related disorder (AUD) (not requiring withdrawal as assessed by an independent psychiatrist) and AUDIT \> 4
  • Smokers: Daily smokers only: smoke 7 days/week during the last three months
  • Non-daily smokers only: smoke at least once but less than 7 days/week during the last three months
  • Ability to consent to the study and complete the questionnaires
  • Sufficient language skills: German
  • Availability between 3pm-6pm on 2 consecutive days (Experiment 1, acute stress question)
  • Females only: luteal phase (Experiment 1, acute stress question)

Exclusion

  • Lifetime diagnosis according to DMS-5 for: Bipolar disorder, schizophrenia, schizophrenia spectrum disorder, substance dependence except for alcohol, nicotine, or cannabis
  • Currently meeting DSM-5 diagnostic criteria for a depressive episode, suicidal ideation
  • Past traumatic brain injury or severe neurological disease (such as dementia, Parkinson's disease, multiple sclerosis)
  • Pregnancy or breastfeeding
  • Ingestion of medications known to interact with the CNS in the 10-day period prior to study participation or less than 4 half-lives after last ingestion (rapid urine test)
  • MR contraindications (e.g., pacemakers, metallic or electronic implants, metallic splinters, surgical staples)
  • Color vision deficiency
  • Sensorineural hearing loss of 30 dB or greater,
  • Tinnitus
  • Presence of claustrophobia
  • Acute alcohol intoxication at MRI appointments verified by breath alcohol testing or drug intoxication verified by rapid urine testing
  • For women only: not peri- or postmenopausal, not taking contraceptives (Experiment 1, acute stress question)

Key Trial Info

Start Date :

November 24 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2024

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT05992272

Start Date

November 24 2020

End Date

December 31 2024

Last Update

August 21 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Charite - Universitätsmedizin Berlin

Berlin, Germany, 10117

2

Technische Universität Dresden

Dresden, Germany, 01307